Showing results (41-50 of 93) with videos related to
Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2020
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin LymphomaLauren Shea, Marcus P Watkins, Fei Wan, et al.Immunity|January 22, 2015
Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphomaOlivia I Koues, Rodney A Kowalewski, Li-Wei Chang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantationIskra Pusic, Shi Yuan Jiang, Scott Landua, et al.Blood|February 7, 2012
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemiaGeoffrey L Uy, Michael P Rettig, Ibraheem H Motabi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL studyNathan Fowler, Brad S Kahl, Peter Lee, et al.The Lancet. Haematology|March 19, 2017
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trialsSonali M Smith, Brandelyn N Pitcher, Sin-Ho Jung, et al.Journal of Clinical and Translational Science|January 12, 2026
Developing a genetic return of results service coreJennifer A McKenzie, Erin McRoy, Kevin M Bowling, et al.Blood Advances|October 23, 2023
Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphomaArmin Ghobadi, Nicole C Foley, Jared Cohen, et al.Ebiomedicine|August 30, 2021
Loss of synergistic transcriptional feedback loops drives diverse B-cell cancersJared M Andrews, Sarah C Pyfrom, Jennifer A Schmidt, et al.American Journal of Hematology|October 7, 2009
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSFMike G Martin, Kristan M Augustin, Geoffrey L Uy, et al.Pageof 10